fbpx

The Latest: Organigram Acquires Motif & ALJ Hearing Schedule

It’s Friday, December 6, 2024, and Beena Goldenberg, CEO of Organigram, joins the Trade To Black Podcast to discuss the company’s acquisition of Motif. We’ve also got some of the key takeaways to share from the MJBiz conference in Las Vegas, and the details about the hemp ban out of Dan Patrick’s office in Texas.

The MJBiz conference in Las Vegas highlighted a cautiously optimistic outlook for the cannabis industry, but it was interesting to see that some of the major publicly traded MSOs went without CEO representation. Instead, private MSOs and brand-focused companies took the center stage. Much discussion centered around increasing lobbying efforts planned for 2025, and industry players are preparing for the possibility of reform under the new administration.

Among the participants at the conference, there seemed to be a strong consensus that rescheduling is likely, but the concerns over bureaucratic delays remain, not to mention pushback from the DEA. Inconsistent state-level regulations and the lack of a unified, national framework continue to pose their own challenges, as seen in Texas. Still, the atmosphere seemed markedly positive, indicating that there’s confidence in the industry’s ability to influence policy. We’ll share our thoughts.

Beena Goldenberg gives us the details about Organigram’s (Nasdaq: OGI) acquisition of Motif. There are expectations that the move will cement them as the #1 LP in Canada from a total marketshare perspective.

We also cover the other headlines this week, including the hemp ban that was hot of out Lt. Governor Dan Patrick’s office down in Texas. The NFL is lowering their standards for drug testing for cannabis in the best way possible. And the ALJ’s schedule, related to the marijuana rescheduling hearing, was released this week. It looks like a pretty practical timeframe. We will be breaking it down and what to expect as this hearing kicks off in the new year.


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More